248 related articles for article (PubMed ID: 29514790)
1.
Xiao P; Dolinska M; Sandhow L; Kondo M; Johansson AS; Bouderlique T; Zhao Y; Li X; Dimitriou M; Rassidakis GZ; Hellström-Lindberg E; Minato N; Walfridsson J; Scadden DT; Sigvardsson M; Qian H
Blood Adv; 2018 Mar; 2(5):534-548. PubMed ID: 29514790
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
[TBL] [Abstract][Full Text] [Related]
3. Sipa1 deficiency unleashes a host-immune mechanism eradicating chronic myelogenous leukemia-initiating cells.
Xu Y; Ikeda S; Sumida K; Yamamoto R; Tanaka H; Minato N
Nat Commun; 2018 Mar; 9(1):914. PubMed ID: 29500416
[TBL] [Abstract][Full Text] [Related]
4. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.
Dong L; Yu WM; Zheng H; Loh ML; Bunting ST; Pauly M; Huang G; Zhou M; Broxmeyer HE; Scadden DT; Qu CK
Nature; 2016 Nov; 539(7628):304-308. PubMed ID: 27783593
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow niche in the myelodysplastic syndromes.
Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
7. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche.
Schepers K; Pietras EM; Reynaud D; Flach J; Binnewies M; Garg T; Wagers AJ; Hsiao EC; Passegué E
Cell Stem Cell; 2013 Sep; 13(3):285-99. PubMed ID: 23850243
[TBL] [Abstract][Full Text] [Related]
8. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
Mattiucci D; Maurizi G; Leoni P; Poloni A
Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis.
Selicean SE; Tomuleasa C; Grewal R; Almeida-Porada G; Berindan-Neagoe I
Leuk Lymphoma; 2019 Apr; 60(4):876-885. PubMed ID: 30277128
[TBL] [Abstract][Full Text] [Related]
10.
Smeets MF; Tan SY; Xu JJ; Anande G; Unnikrishnan A; Chalk AM; Taylor SR; Pimanda JE; Wall M; Purton LE; Walkley CR
Blood; 2018 Aug; 132(6):608-621. PubMed ID: 29903888
[TBL] [Abstract][Full Text] [Related]
11. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia.
Kim JA; Shim JS; Lee GY; Yim HW; Kim TM; Kim M; Leem SH; Lee JW; Min CK; Oh IH
Cancer Res; 2015 Jun; 75(11):2222-31. PubMed ID: 25791383
[TBL] [Abstract][Full Text] [Related]
12. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms.
Arranz L; Sánchez-Aguilera A; Martín-Pérez D; Isern J; Langa X; Tzankov A; Lundberg P; Muntión S; Tzeng YS; Lai DM; Schwaller J; Skoda RC; Méndez-Ferrer S
Nature; 2014 Aug; 512(7512):78-81. PubMed ID: 25043017
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia.
Tang C; Li MH; Chen YL; Sun HY; Liu SL; Zheng WW; Zhang MY; Li H; Fu W; Zhang WJ; Liang AB; Tang ZH; Hong DL; Zhou BS; Duan CW
J Exp Clin Cancer Res; 2018 Aug; 37(1):204. PubMed ID: 30157922
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the
Stoddart A; Wang J; Hu C; Fernald AA; Davis EM; Cheng JX; Le Beau MM
Blood; 2017 Jun; 129(22):2959-2970. PubMed ID: 28348148
[TBL] [Abstract][Full Text] [Related]
15. IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms.
Mager LF; Riether C; Schürch CM; Banz Y; Wasmer MH; Stuber R; Theocharides AP; Li X; Xia Y; Saito H; Nakae S; Baerlocher GM; Manz MG; McCoy KD; Macpherson AJ; Ochsenbein AF; Beutler B; Krebs P
J Clin Invest; 2015 Jul; 125(7):2579-91. PubMed ID: 26011644
[TBL] [Abstract][Full Text] [Related]
16. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?
Ramos TL; Sánchez-Abarca LI; Redondo A; Hernández-Hernández Á; Almeida AM; Puig N; Rodríguez C; Ortega R; Preciado S; Rico A; Muntión S; Porras JRG; Del Cañizo C; Sánchez-Guijo F
Oncotarget; 2017 Apr; 8(17):28187-28202. PubMed ID: 28390197
[TBL] [Abstract][Full Text] [Related]
17. Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression.
Klein C; Zwick A; Kissel S; Forster CU; Pfeifer D; Follo M; Illert AL; Decker S; Benkler T; Pahl H; Oostendorp RA; Aumann K; Duyster J; Dierks C
J Exp Med; 2016 Feb; 213(2):273-90. PubMed ID: 26834157
[TBL] [Abstract][Full Text] [Related]
18. CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow.
Nakamura-Ishizu A; Takubo K; Kobayashi H; Suzuki-Inoue K; Suda T
J Exp Med; 2015 Nov; 212(12):2133-46. PubMed ID: 26552707
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis.
Ramos TL; Sánchez-Abarca LI; Rosón-Burgo B; Redondo A; Rico A; Preciado S; Ortega R; Rodríguez C; Muntión S; Hernández-Hernández Á; De Las Rivas J; González M; González Porras JR; Del Cañizo C; Sánchez-Guijo F
PLoS One; 2017; 12(8):e0182470. PubMed ID: 28796790
[TBL] [Abstract][Full Text] [Related]
20. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]